AlzeCure Pharma AB announced that its abstract on NeuroRestore ACD856 has been accepted for presentation at the AD/PD 2025 ...

The network of European distributors kicks off the year with an online session dedicated to learning, sharing and ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Presentation Operator Good day, and thank you for standing-by. Welcome to the Q4 2024 Intuitive Earnings Conference Call. At ...

Results from the study have been accepted as a poster presentation at the ASCO Gastrointestinal Cancers ... Two grade 3 adverse events (AEs) - one case of diarrhea and one case of syncope - were ...

Progressing first-in-class, tissue-tethered autoimmune platform – Type 1 diabetes candidate on track for CTA submission in 2025; first universal candidate targeting CD1a initially for atopic ...

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to ...

Prioritizing commercial efforts in the U.S., resulting in plans for incremental reduction of ex-U.S. footprint by approximately 40 employees. Initiation of Phase 1b/2 multi-dose study of APL ...

STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases af ...

Pittcon addresses food contamination issues, focusing on trace metals and microplastics in chowder, highlighting advanced ...

A fifteen-year-old boy navigates first love, familial pressure and his newfound love of music in DJ Ahmet, premiering in the 2025 Sundance Film Festival’s World Cinema Dramatic Competition. The film ...